Arthritis Foundation Corporate Sponsorship: UCB's ongoing sponsorship of the Arthritis Foundation helps to raise awareness about arthritis, strengthen research efforts, and provide education to patients living with arthritis.
RA Local Events Sponsorships: UCB supports a number of local events for people living with rheumatoid arthritis to help educate individuals on managing their arthritis and to provide information on resources and tools to assist patients with improving.
For further Information:
Andrea Levin, Senior Manager, Communications and PR, UCB, Inc.
Dena Koklanaris, Cooney/Waters Group
About Rheumatoid Arthritis (RA)
RA affects more than 1.3 million Americans, and it is estimated that 5 million people suffer from RA globally. Prevalence is not split evenly between genders, since women are three times more likely to be affected than men. Although RA can affect people of all ages, the onset of the disease usually occurs between 35-55 years of age.
UCB, Brussels, Belgium (www.ucb-usa.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8,500 people in more than 40 countries, the company generated revenue of euro 3.2 billion in 2010. UCB is listed on Euronext Brussels (symbol: UCB).
For further information on UCB products, please visit www.UCB.com.
Forward looking statement
Copyright©2010 PR Newswire.
All rights reserved